Skip to main content
Erschienen in: Supportive Care in Cancer 9/2014

01.09.2014 | Original Article

Feasibility and acceptance of electronic monitoring of symptoms and syndromes using a handheld computer in patients with advanced cancer in daily oncology practice

verfasst von: D. Blum, D. Koeberle, A. Omlin, J. Walker, R. Von Moos, W. Mingrone, S. deWolf-Linder, S. Hayoz, S. Kaasa, F. Strasser, K. Ribi

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We investigated the feasibility and acceptance of electronic monitoring of symptoms and syndromes in oncological outpatient clinics using a PALM (handheld computer).

Methods

The assessment of a combination of symptoms and clinical benefit parameters grouped in four pairs was tested in a pilot phase in advanced cancer patients. Based on these experiences, the software E-MOSAIC was developed, consisting of patient-reported symptoms and nutritional intake and objective assessments (weight, weight loss, performance status and medication for pain, fatigue, and cachexia). E-MOSAIC was then tested in four Swiss oncology centers. In order to compare the methods, patients completed the E-MOSAIC as a paper and a PALM version. Preferences of version and completion times were collected. Assessments were compared using Wilcoxon signed-rank tests , and the test-retest reliability was evaluated.

Results

The pilot phase was completed by 22 patients. Most patients and physicians perceived the assessment as useful. Sixty-two patients participated in the feasibility study. Twelve patients reported problems (understanding, optical, tactile), and five patients could not complete the assessment. The median time to complete the PALM-based assessment was 3 min. Forty-nine percent of patients preferred the PALM, 23 % preferred a paper version, and 28 % of patients had no preference. Paper vs. PALM revealed no significant differences in symptoms, but in nutritional intake (p = 0.013). Test-retest (1 h, n = 20) reliability was satisfactory (r = 073–98).

Conclusion

Electronic symptom and clinical benefit monitoring is feasible in oncology outpatient clinics and perceived as useful by patients, oncology nurses, and oncologists. E-MOSAIC is tested in a prospective randomized trial.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abernethy AP, Currow DC (2011) Patient self-reporting in palliative care using information technology: yes, there is hope! Palliat Med 25:673–674PubMedCrossRef Abernethy AP, Currow DC (2011) Patient self-reporting in palliative care using information technology: yes, there is hope! Palliat Med 25:673–674PubMedCrossRef
2.
Zurück zum Zitat Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, McCabe M, Schrag D (2007) Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 25:5374–5380PubMedCrossRef Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, McCabe M, Schrag D (2007) Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol 25:5374–5380PubMedCrossRef
3.
Zurück zum Zitat Bernhard J, Dietrich D, Scheithauer W, Gerber D, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schuller J, Saletti P, Bauer J, Figer A, Pestalozzi BC, Kohne C-H, Mingrone W, Stemmer SM, Tàmas K, Kornek GV, Koeberle D, Herrmann R (2008) Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial–SAKK 44/00-CECOG/PAN.1.3.001. J Clin Oncol 26:3695–3701PubMedCrossRef Bernhard J, Dietrich D, Scheithauer W, Gerber D, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schuller J, Saletti P, Bauer J, Figer A, Pestalozzi BC, Kohne C-H, Mingrone W, Stemmer SM, Tàmas K, Kornek GV, Koeberle D, Herrmann R (2008) Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial–SAKK 44/00-CECOG/PAN.1.3.001. J Clin Oncol 26:3695–3701PubMedCrossRef
4.
Zurück zum Zitat Berry DL, Blumenstein BA, Halpenny B, Wolpin S, Fann JR, Austin-Seymour M, Bush N, Karras BT, Lober WB, McCorkle R (2011) Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol 29:1029–1035PubMedCentralPubMedCrossRef Berry DL, Blumenstein BA, Halpenny B, Wolpin S, Fann JR, Austin-Seymour M, Bush N, Karras BT, Lober WB, McCorkle R (2011) Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol 29:1029–1035PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Blum D, Koeberle D, Ribi K, Hsu Schmitz SF, Uitger U, Klingbiel D, Strasser F (2012) Electronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC. BMC palliative care 11:19PubMedCentralPubMedCrossRef Blum D, Koeberle D, Ribi K, Hsu Schmitz SF, Uitger U, Klingbiel D, Strasser F (2012) Electronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC. BMC palliative care 11:19PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed
7.
Zurück zum Zitat Buxton J, White M, Osoba D (1998) Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res Int J Qual Life Asp Treat Care Rehab 7:513–519CrossRef Buxton J, White M, Osoba D (1998) Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res Int J Qual Life Asp Treat Care Rehab 7:513–519CrossRef
8.
Zurück zum Zitat Chan CW, Tam W, Cheng KK, Chui YY, So WK, Mok T, Wong C, McReynolds J, Berry DL (2011) Piloting electronic self report symptom assessment—cancer (ESRA-C) in Hong Kong: a mixed method approach. Eur J Oncol Nurs 15:325–334PubMedCrossRef Chan CW, Tam W, Cheng KK, Chui YY, So WK, Mok T, Wong C, McReynolds J, Berry DL (2011) Piloting electronic self report symptom assessment—cancer (ESRA-C) in Hong Kong: a mixed method approach. Eur J Oncol Nurs 15:325–334PubMedCrossRef
9.
Zurück zum Zitat Cox A, Illsley M, Knibb W, Lucas C, O'Driscoll M, Potter C, Flowerday A, Faithfull S (2011) The acceptability of e-technology to monitor and assess patient symptoms following palliative radiotherapy for lung cancer. Palliat Med 25:675–681PubMedCrossRef Cox A, Illsley M, Knibb W, Lucas C, O'Driscoll M, Potter C, Flowerday A, Faithfull S (2011) The acceptability of e-technology to monitor and assess patient symptoms following palliative radiotherapy for lung cancer. Palliat Med 25:675–681PubMedCrossRef
10.
Zurück zum Zitat Cull A, Gould A, House A, Smith A, Strong V, Velikova G, Wright P, Selby P (2001) Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Br J Cancer 85:1842–1849PubMedCentralPubMedCrossRef Cull A, Gould A, House A, Smith A, Strong V, Velikova G, Wright P, Selby P (2001) Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Br J Cancer 85:1842–1849PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Detmar SB, Aaronson NK (1998) Quality of life assessment in daily clinical oncology practice: a feasibility study. Eur J Cancer 34:1181–1186PubMedCrossRef Detmar SB, Aaronson NK (1998) Quality of life assessment in daily clinical oncology practice: a feasibility study. Eur J Cancer 34:1181–1186PubMedCrossRef
12.
Zurück zum Zitat Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK (2002) Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 288:3027–3034PubMedCrossRef Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK (2002) Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 288:3027–3034PubMedCrossRef
13.
Zurück zum Zitat Doyle C, Crump M, Pintilie M, Oza AM (2001) Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol 19:1266–1274PubMed Doyle C, Crump M, Pintilie M, Oza AM (2001) Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol 19:1266–1274PubMed
14.
Zurück zum Zitat Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? JAMA 283:2701–2711PubMedCrossRef Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? JAMA 283:2701–2711PubMedCrossRef
15.
Zurück zum Zitat Fisch MJ, Titzer ML, Kristeller JL, Shen J, Loehrer PJ, Jung S-H, Passik SD, Einhorn LH (2003) Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being–a Hoosier Oncology Group Study. J Clin Oncol 21:2754–2759PubMedCrossRef Fisch MJ, Titzer ML, Kristeller JL, Shen J, Loehrer PJ, Jung S-H, Passik SD, Einhorn LH (2003) Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being–a Hoosier Oncology Group Study. J Clin Oncol 21:2754–2759PubMedCrossRef
16.
Zurück zum Zitat Gough IR, Dalgleish LI (1991) What value is given to quality of life assessment by health professionals considering response to palliative chemotherapy for advanced cancer? Cancer 68:220–225PubMedCrossRef Gough IR, Dalgleish LI (1991) What value is given to quality of life assessment by health professionals considering response to palliative chemotherapy for advanced cancer? Cancer 68:220–225PubMedCrossRef
17.
Zurück zum Zitat Gwaltney CJ, Shields AL, Shiffman S (2008) Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health 11:322–333PubMedCrossRef Gwaltney CJ, Shields AL, Shiffman S (2008) Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health 11:322–333PubMedCrossRef
18.
Zurück zum Zitat Hjermstad MJ, Lie HC, Caraceni A, Currow DC, Fainsinger RL, Gundersen OE, Haugen DF, Heitzer E, Radbruch L, Stone PC, Strasser F, Kaasa S, Loge JH (2012) Computer-Based symptom assessment is feasible in patients with advanced cancer: results from an International Multicenter Study, the EPCRC-CSA. Journal of pain and symptom management Hjermstad MJ, Lie HC, Caraceni A, Currow DC, Fainsinger RL, Gundersen OE, Haugen DF, Heitzer E, Radbruch L, Stone PC, Strasser F, Kaasa S, Loge JH (2012) Computer-Based symptom assessment is feasible in patients with advanced cancer: results from an International Multicenter Study, the EPCRC-CSA. Journal of pain and symptom management
19.
Zurück zum Zitat Hollen PJ, Gralla RJ, Stewart JA, Meharchand JM, Wierzbicki R, Leighl N (2013) Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL). Support Care Cancer 21:165–172PubMedCrossRef Hollen PJ, Gralla RJ, Stewart JA, Meharchand JM, Wierzbicki R, Leighl N (2013) Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL). Support Care Cancer 21:165–172PubMedCrossRef
20.
Zurück zum Zitat Kaasa S, Loge JH, Fayers P, Caraceni A, Strasser F, Hjermstad MJ, Higginson I, Radbruch L, Haugen DF (2008) Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol 26:3867–3873PubMedCrossRef Kaasa S, Loge JH, Fayers P, Caraceni A, Strasser F, Hjermstad MJ, Higginson I, Radbruch L, Haugen DF (2008) Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol 26:3867–3873PubMedCrossRef
21.
Zurück zum Zitat Kearney N, Kidd L, Miller M, Sage M, Khorrami J, McGee M, Cassidy J, Niven K, Gray P (2006) Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study. Support Care Cancer 14:742–752PubMedCrossRef Kearney N, Kidd L, Miller M, Sage M, Khorrami J, McGee M, Cassidy J, Niven K, Gray P (2006) Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study. Support Care Cancer 14:742–752PubMedCrossRef
22.
Zurück zum Zitat Laugsand EA, Jakobsen G, Kaasa S, Klepstad P (2011) Inadequate symptom control in advanced cancer patients across Europe. Support Care Cancer 19:2005–2014PubMedCentralPubMedCrossRef Laugsand EA, Jakobsen G, Kaasa S, Klepstad P (2011) Inadequate symptom control in advanced cancer patients across Europe. Support Care Cancer 19:2005–2014PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Michael M, Hedley D, Oza A, Feld R, Pintilie M, Goel R, Maroun J, Jolivet J, Fields A, Lee IM, Moore MJ (2002) The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a multicenter Canadian trial. Clin Color Cancer 2:93–101CrossRef Michael M, Hedley D, Oza A, Feld R, Pintilie M, Goel R, Maroun J, Jolivet J, Fields A, Lee IM, Moore MJ (2002) The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a multicenter Canadian trial. Clin Color Cancer 2:93–101CrossRef
24.
Zurück zum Zitat Mullen KH, Berry DL, Zierler BK (2004) Computerized symptom and quality-of-life assessment for patients with cancer part II: acceptability and usability. Oncol Nurs Forum 31:E84–89PubMedCrossRef Mullen KH, Berry DL, Zierler BK (2004) Computerized symptom and quality-of-life assessment for patients with cancer part II: acceptability and usability. Oncol Nurs Forum 31:E84–89PubMedCrossRef
25.
Zurück zum Zitat Oliver DR, Demiris G (2004) An assessment of the readiness of hospice organizations to accept technological innovation. J Telemed Telecare 10:170–174PubMedCrossRef Oliver DR, Demiris G (2004) An assessment of the readiness of hospice organizations to accept technological innovation. J Telemed Telecare 10:170–174PubMedCrossRef
26.
Zurück zum Zitat Passik SD, Kirsh KL (2000) The importance of quality-of-life endpoints in clinical trials to the practicing oncologist. Hematol Oncol Clin North Am 14:877–886PubMedCrossRef Passik SD, Kirsh KL (2000) The importance of quality-of-life endpoints in clinical trials to the practicing oncologist. Hematol Oncol Clin North Am 14:877–886PubMedCrossRef
27.
Zurück zum Zitat Ruland CM, Holte HH, Roislien J, Heaven C, Hamilton GA, Kristiansen J, Sandbaek H, Kvaloy SO, Hasund L, Ellison MC (2010) Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial. J Am Med Inform Assoc 17:403–410PubMedCentralPubMedCrossRef Ruland CM, Holte HH, Roislien J, Heaven C, Hamilton GA, Kristiansen J, Sandbaek H, Kvaloy SO, Hasund L, Ellison MC (2010) Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial. J Am Med Inform Assoc 17:403–410PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Taenzer P, Bultz BD, Carlson LE, Speca M, DeGagne T, Olson K, Doll R, Rosberger Z (2000) Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psycho-oncology 9:203–213PubMedCrossRef Taenzer P, Bultz BD, Carlson LE, Speca M, DeGagne T, Olson K, Doll R, Rosberger Z (2000) Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients. Psycho-oncology 9:203–213PubMedCrossRef
29.
Zurück zum Zitat Velikova G, Brown JM, Smith AB, Selby PJ (2002) Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer 86:51–59PubMedCentralPubMedCrossRef Velikova G, Brown JM, Smith AB, Selby PJ (2002) Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer 86:51–59PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Velikova G, Wright P, Smith AB, Stark D, Perren T, Brown J, Selby P (2001) Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records. J Clin Oncol 19:2064–2073PubMed Velikova G, Wright P, Smith AB, Stark D, Perren T, Brown J, Selby P (2001) Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records. J Clin Oncol 19:2064–2073PubMed
31.
Zurück zum Zitat Wilkie DJ, Judge MK, Berry DL, Dell J, Zong S, Gilespie R (2003) Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain. J Pain Symptom Manag 25:213–224CrossRef Wilkie DJ, Judge MK, Berry DL, Dell J, Zong S, Gilespie R (2003) Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain. J Pain Symptom Manag 25:213–224CrossRef
32.
Zurück zum Zitat Wright EP, Selby PJ, Crawford M, Gillibrand A, Johnston C, Perren TJ, Rush R, Smith A, Velikova G, Watson K, Gould A, Cull A (2003) Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 21:374–382PubMedCrossRef Wright EP, Selby PJ, Crawford M, Gillibrand A, Johnston C, Perren TJ, Rush R, Smith A, Velikova G, Watson K, Gould A, Cull A (2003) Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 21:374–382PubMedCrossRef
Metadaten
Titel
Feasibility and acceptance of electronic monitoring of symptoms and syndromes using a handheld computer in patients with advanced cancer in daily oncology practice
verfasst von
D. Blum
D. Koeberle
A. Omlin
J. Walker
R. Von Moos
W. Mingrone
S. deWolf-Linder
S. Hayoz
S. Kaasa
F. Strasser
K. Ribi
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2201-8

Weitere Artikel der Ausgabe 9/2014

Supportive Care in Cancer 9/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.